Discover how the 340B drug pricing program, intended to help low-income patients, has become a system of abuse and misuse ...

What Happened: The legal spat stems from the federal 340B Drug Pricing Program, which provides discounted medications to ...

Lindsay Bealor Greenleaf, JD, MBA, of ADVI Health, weighs in on what to expect in key health care policy areas in the wake of ...

Sandoz Inc., Pfizer Inc., and Amneal Pharmaceuticals Inc. are among a group of generic-drug manufacturers that will face some ...

Walgreens has agreed to pay $100 million to settle a proposed class action lawsuit accusing it of fraudulently overcharging ...

Novo Nordisk is scheduled to report results for the third quarter on Wednesday. Here is what you need to know: NET PROFIT FORECAST: Net profit in the quarter is expected to rise 19% to 26.79 billion ...

More recent acquisitions in 2024—oncology firms Mirati and RayzeBio and neurology firm Karuna—also help support Bristol's strong overall pipeline and wide moat. Bristol has created a strong pipeline ...

People with multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, and that amount soared to $2,378 annually in 2021, according to a new study. The study  examined the ...

Drug-related supply chain issues in Canada were 40% less likely to result in significant drug shortages than in the United ...

In a decisive move, the European Union’s antitrust authority fined Teva Pharmaceutical Industries €463 million ($502 million) ...

Request To Download Free Sample of This Strategic Report @ The publisher has been vigilantly tracking the diverse markets within Saudi Arabia. This report presents an extensive analysis, encompassing ...